Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioMarin's Q1 Loss Shrinks 79% Due to Higher Rare Disease Drug Sales
BioMarin's Q1 Loss Shrinks 79% Due to Higher Rare Disease Drug Sales
BioMarin's Q1 Loss Shrinks 79% Due to Higher Rare Disease Drug Sales
Submitted by
admin
on May 2, 2014 - 8:38am
Source:
Motley Fool
News Tags:
Biomarin
earnings
Headline:
BioMarin's Q1 Loss Shrinks 79% Due to Higher Rare Disease Drug Sales
Do Not Allow Advertisers to Use My Personal information
